June 5: Dr. Steven M. Dubinett, a leader in the fields of pulmonology and translational research, has been named dean of the David Geffen School of Medicine at UCLA.
Dubinett, who was associate vice chancellor for research at UCLA and senior associate dean for translational research at the DGSOM, is a founding director of the UCLA Clinical & Translational Science Institute, which is a consortium of four Los Angeles institutions that are enhancing the translation of basic research into drugs, medical devices, tools and interventions that improve health. He joined the medical school’s faculty in 1988 and has served as interim dean since September 2021. He was selected following a national search.
Executive Vice Chancellor and Provost Darnell Hunt, in an announcement to the campus community, said, “Dean Dubinett is well-equipped to helm the DGSOM and to advance its strategic goals — including partnering with colleagues to deepen the school’s commitment to justice, equity, diversity and inclusion in alignment with UCLA’s overall focus on inclusive excellence; elevating the school’s profile in academic research; and expanding its engagement with underserved communities in Los Angeles.”
Dr. John Mazziotta, vice chancellor for health sciences and CEO of UCLA Health, said, “Dean Dubinett has demonstrated a strong capacity for advancing basic, translational, clinical and community-engaged research at the DGSOM. His decades of experience in research administration and translational science will enable him to serve the research and clinical mission areas of the school well.” Dr. Mazziotta added, “Perhaps most importantly, he has a long history of commitment to collaborative partnerships with colleagues and mentorship of graduate students, post-doctoral fellows and junior faculty.” ...
Full news release at https://www.uclahealth.org/news/translational-research-leader-named-dean-david-geffen-school.
No comments:
Post a Comment